Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
Project Oncology®Exploring Elacestrant Combinations for ER+/HER2- mBC: Early Data from ELEVATE
Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
Project Oncology®Elacestrant and Targeted Therapies in Breast Cancer: Preliminary Data From ELECTRA and ELEVATE
Easing the Perimenopause Transition with IUDs: Key Clinical Considerations
Advances in Women's HealthEasing the Perimenopause Transition with IUDs: Key Clinical Considerations
Exercise in Osteoporosis Care: Guideline-Based Strategies for Fracture Prevention
On the Frontlines of OsteoporosisExercise in Osteoporosis Care: Guideline-Based Strategies for Fracture Prevention
Optimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
Advances in Women's HealthOptimizing Outcomes in Endometrial Cancer: From Surgery to Recurrence Management
Clinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Advances in Women's HealthClinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
- advertisement
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
CME/CEHER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
CME/CEThe Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
CME/CE Broadcast ReplayNew Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CEWhy Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
- advertisement
The Unmet Need in 1L HR+/HER2− Advanced Breast Cancer
Medical Industry FeatureThe Unmet Need in 1L HR+/HER2− Advanced Breast Cancer
New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Medical Industry FeatureNew 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Medical Industry FeatureTreating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
The Value of CINtec®PLUS Cytology Test in Cervical Cancer Screening
Advances in Women's HealthThe Value of CINtec®PLUS Cytology Test in Cervical Cancer Screening
Freeze-All Policy: Is It Right for Everyone?
Global Women's Health AcademyFreeze-All Policy: Is It Right for Everyone?
- 09/18/2025
- 09/16/2025
- 09/16/2025
- 09/15/2025
- 09/12/2025
- 09/12/2025